This leaflet answers some common questions about ENERZAIR BREEZHALER. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

Novartis has moved a step closer to EU approval of its three-drug asthma therapy Enerzair Breezhaler, and now looks set to beat a rival therapy from GlaxoSmithKline to market. Enerzair (formerly ...

can you play rummy with 6 players Official news: "Rural Doctor Loan" is here Novartis' high-dose Enerzair Breezhaler significantly reduces the rate of moderate to severe asthma exacerbations The ...